These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38406573)

  • 1. The influence of uremic toxins on low bone turnover disease in chronic kidney disease.
    Yiang GT; Su WL; Zheng CM; Liao MT; Cheng TH; Lu CL; Lu KC
    Tzu Chi Med J; 2024; 36(1):38-45. PubMed ID: 38406573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways.
    Tanaka H; Iwasaki Y; Yamato H; Mori Y; Komaba H; Watanabe H; Maruyama T; Fukagawa M
    Bone; 2013 Oct; 56(2):347-54. PubMed ID: 23851293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease.
    Hung KC; Yao WC; Liu YL; Yang HJ; Liao MT; Chong K; Peng CH; Lu KC
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of uremic toxin-indoxyl sulfate on the skeletal system.
    Liu WC; Wu CC; Lim PS; Chien SW; Hou YC; Zheng CM; Shyu JF; Lin YF; Lu KC
    Clin Chim Acta; 2018 Sep; 484():197-206. PubMed ID: 29864403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption.
    Watanabe K; Tominari T; Hirata M; Matsumoto C; Hirata J; Murphy G; Nagase H; Miyaura C; Inada M
    FEBS Open Bio; 2017 Aug; 7(8):1178-1185. PubMed ID: 28781957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
    Chao CT; Lin SH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic Toxicity and Bone in CKD.
    Yamamoto S; Fukagawa M
    J Nephrol; 2017 Oct; 30(5):623-627. PubMed ID: 28573386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease.
    Lu CL; Zheng CM; Lu KC; Liao MT; Wu KL; Ma MC
    Antioxidants (Basel); 2021 Jun; 10(6):. PubMed ID: 34207816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fragility Fractures in Hemodialysis Patients. Uremic toxins-related abnormal bone metabolism.].
    Yamamoto S
    Clin Calcium; 2018; 28(8):1093-1100. PubMed ID: 30049919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.
    Nii-Kono T; Iwasaki Y; Uchida M; Fujieda A; Hosokawa A; Motojima M; Yamato H; Kurokawa K; Fukagawa M
    Kidney Int; 2007 Apr; 71(8):738-43. PubMed ID: 17264878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate promotes apoptosis in cultured osteoblast cells.
    Kim YH; Kwak KA; Gil HW; Song HY; Hong SY
    BMC Pharmacol Toxicol; 2013 Dec; 14():60. PubMed ID: 24289746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scavenging Intracellular ROS Attenuates
    Chang JF; Hsieh CY; Liou JC; Liu SH; Hung CF; Lu KC; Lin CC; Wu CC; Ka SM; Wen LL; Wu MS; Zheng CM; Ko WC
    Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32722241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic toxins activate CREB/ATF1 in endothelial cells related to chronic kidney disease.
    Stafim da Cunha R; Gregório PC; Maciel RAP; Favretto G; Franco CRC; Gonçalves JP; de Azevedo MLV; Pecoits-Filho R; Stinghen AEM
    Biochem Pharmacol; 2022 Apr; 198():114984. PubMed ID: 35245485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing bone patterns with progression of chronic kidney disease.
    Drüeke TB; Massy ZA
    Kidney Int; 2016 Feb; 89(2):289-302. PubMed ID: 26806832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoxyl Sulfate Induces Apoptosis Through Oxidative Stress and Mitogen-Activated Protein Kinase Signaling Pathway Inhibition in Human Astrocytes.
    Lin YT; Wu PH; Tsai YC; Hsu YL; Wang HY; Kuo MC; Kuo PL; Hwang SJ
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30764571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Bone Turnover in Chronic Kidney Disease Is Associated with Decreased VEGF-A Expression and Osteoblast Differentiation.
    Chen NX; O'Neill KD; Allen MR; Newman CL; Moe SM
    Am J Nephrol; 2015; 41(6):464-73. PubMed ID: 26228644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.